TNG.PA PAR
Transgene S.A.
1W: -7.9%
1M: -20.9%
3M: -9.3%
YTD: -16.9%
1Y: -38.6%
3Y: -59.5%
5Y: -72.8%
€0.70 ($0.78)
-0.01 (-1.96%)
Weekly Expected Move ±4.8%
€1
€1
€1
€1
€1
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Income Trends
Revenue
$137K
-97.8% ▼
5Y CAGR: -46.0%
Gross Profit
$0
+100.0% ▲
Operating Income
-$41M
-15.2% ▼
Net Income
-$38M
-10.5% ▼
EPS (Diluted)
$-0.26
+10.3% ▲
EBITDA
-$40M
-49.2% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $10M | $3M | $8M | $6M | $137K |
| YoY Growth | +235.2% | -68.7% | +152.7% | -19.6% | -97.8% |
| Cost of Revenue | $33M | $32M | $30M | $34M | $0 |
| Gross Profit | -$23M | -$29M | -$22M | -$28M | $0 |
| Gross Margin | -229.1% | -929.0% | -274.5% | -439.6% | 0.0% |
| R&D Expenses | $33M | $32M | $30M | $34M | $33M |
| SG&A Expenses | $3M | $3M | $4M | $4K | $7M |
| Operating Expenses | $34M | $33M | $8M | $8M | $40M |
| Operating Income | -$24M | -$30M | -$30M | -$36M | -$41M |
| Operating Margin | -235.4% | -956.6% | -380.3% | -561.3% | -29978.1% |
| Interest Expense | $464K | $804K | $0 | $2M | $2M |
| Income Before Tax | -$20M | -$33M | -$22M | -$40M | -$44M |
| Tax Expense | $468K | $6K | $0 | $0 | -$7M |
| Net Income | -$20M | -$33M | -$22M | -$34M | -$38M |
| Net Margin | -200.2% | -1049.6% | -282.6% | -534.7% | -27389.8% |
| EPS (Diluted) | $-0.22 | $-0.33 | $-0.22 | $-0.29 | $-0.26 |
| EBITDA | -$24M | -$30M | -$28M | -$27M | -$40M |
| Shares Outstanding | 91M | 100M | 101M | 117M | 144M |